US equities
|
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
META
$630.56
▼-1.88%
NVDA
$216.00
▲+2.39%
AAPL
$343.91
▼-1.10%
SPCX
$146.90
▼-0.40%
MSFT
$532.60
▲+1.54%
AMD
$531.28
▲+2.80%
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
META
$630.56
▼-1.88%
NVDA
$216.00
▲+2.39%
AAPL
$343.91
▼-1.10%
SPCX
$146.90
▼-0.40%
MSFT
$532.60
▲+1.54%
AMD
$531.28
▲+2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Equillium, Inc. - Common Stock
(NQ:
EQ
)
1.250
+0.020 (+1.63%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Equillium, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021
September 30, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 22, 2021
From
Equillium, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021
↗
September 15, 2021
Upgrades For Alcoa Corp (NYSE:
Via
Benzinga
Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
From
Equillium, Inc.
Via
Business Wire
60 Biggest Movers From Yesterday
↗
August 24, 2021
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via
Benzinga
Equillium's Itolizumab Reduces Urine Protein In Lupus Patients
↗
August 12, 2021
Equillium Inc (NASDAQ: EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 11, 2021
Gainers Hims & Hers Health (NYSE:HIMS)...
Via
Benzinga
Equillium Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
August 11, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
August 10, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at the BTIG Virtual Biotechnology Conference
August 05, 2021
From
Equillium, Inc.
Via
Business Wire
Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab
↗
July 13, 2021
Equillium Inc (NASDAQ: EQ) completed an End-of-Phase 1 meeting with the FDA, confirming to advance itolizumab into a single Phase 3 pivotal study in first-line...
Via
Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
↗
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 12, 2021
Gainers SCWorx (NASDAQ:WORX) shares rose...
Via
Benzinga
64 Biggest Movers From Friday
↗
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
12 Health Care Stocks Moving In Friday's Intraday Session
↗
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...
Via
Benzinga
Equillium's Itolizumab Shows Rapid, Durable Responses In Graft-Versus-Host-Disease Patients
↗
June 11, 2021
Equillium Inc (NASDAQ: EQ) has announced positive topline data from the Phase 1b EQUATE study evaluating itolizumab in first-line acute graft-versus-host-disease (...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...
Via
Benzinga
46 Biggest Movers From Yesterday
↗
April 21, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it...
Via
Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
↗
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
